SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-134914
Filing Date
2023-05-04
Accepted
2023-05-04 06:08:41
Documents
3
Group Members
CONCENTRA BIOSCIENCES, LLCTANG CAPITAL MANAGEMENT, LLCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d266358dsctota.htm SC TO-T/A 31470
2 EX-99.(D)(5) d266358dex99d5.htm EX-99.(D)(5) 140145
3 EX-FILING FEES d266358dexfilingfees.htm EX-FILING FEES 15718
  Complete submission text file 0001193125-23-134914.txt   188968
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-89831 | Film No.: 23886236
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 (858) 200-3830
Concentra Merger Sub, Inc. (Filed by) CIK: 0001972123 (see all company filings)

IRS No.: 923233597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A